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ABSTRACT 
Enhancing quality of life and reducing the unmet needs of women are central to the 
successful management of advanced breast cancer. The objective of this study was to 
investigate the quality of life and support and information needs of urban women with 
advanced breast cancer. This study was conducted at four large urban hospitals in 
Melbourne, Australia. A consecutive sample of 105 women with advanced breast 
cancer completed a questionnaire that contained the European Organization of 
Research and Treatment of Cancer Quality of Life Q-C30 and the Supportive Care 
Needs Survey. Between one quarter and a third of the women reported difficulties 
with their physical, role and social functioning, and a little over a quarter of the 
women reported poor global health status. Fatigue was a problem for most women. 
The highest unmet needs were in the psychological and health information domains. 
Almost no differences in unmet needs were detected when comparing different 
demographic and disease characteristics of women. Health care providers should 
routinely monitor the quality of life and needs of women with advanced breast cancer 
to ensure that appropriate treatment, information or supportive services are made 
available. 
 
INTRODUCTION 
Breast cancer is the most commonly detected cancer and the most common cause of 
cancer death amongst women in more economically developed countries (Stewart & 
Kleihues 2003). Even with early intervention, there is a life-long risk of recurrence 
even 30 years or more after initial diagnosis of breast cancer (DeVita et al. 2001). 
Increasingly, advanced breast cancer is being conceptualized as a chronic illness 
(Brescia et al. 1990). Women can live with the disease for 10 years or more 
depending upon the location and extent of metastases (DeVita et al. 2001). However, 
there is evidence that the psychosocial care of women with advanced breast cancer is 
currently lacking (Parle et al. 2001; Scholten et al. 2001;Coristine et al. 2003). An 
Australian audit study showed that of the 842 women seen by four breast cancer 
nurses only 7% were women with advanced disease, despite the fact that this group 
represented 35% of breast cancer cases in the hospitals where the study was 
conducted (Aranda et al. 2002). Given the sizeable number of women who are now 
living with advanced breast cancer (Stewart & Kleihues 2003), it is critical that efforts 
are directed towards reducing cancer-related morbidity and improving the quality of 
patient care. Optimal care involves not only the technical or disease management 
aspects but also meeting the needs of the patient in the psychosocial, supportive care 
and informational domains (Sackett et al. 1996;AFCOS 1998; Donabedian 1988). 
This study investigates the needs of urban women with advanced breast cancer. The 
results will show the development of interventions designed to meet these needs and 
enhance these women's quality and length of life. 
 
Quality of life assesses two aspects of experience: the persons' functional status across 
various domains, such as, physical, occupational and interpersonal, and the persons' 
appraisal of how their health affects their enjoyment or quality of life (Fayers & 
Bottomley 2002). However, definitions vary, as do approaches to measurement 
(Muldoon et al. 1998). Some instruments attempt to measure these dimensions 
objectively by seeking behavioural information about tasks that can be performed, and 
others assess quality of life in an inherently subjective way by asking about how the 
person feels (Muldoon et al. 1998). Concerns have been raised over the validity of 
commonly used instruments because criterion validation, which is the best method of 
assessing validity, has not been demonstrated (Muldoon et al. 1998). Also, person 
characteristics, such as personality, cognitive dysfunction and psychological 
adaptation to illness may influence how a person responds to the items (Muldoon et 
al. 1998; Slevin et al. 1988). 
 
Nevertheless, quality of life has been found to be a significant independent predictor 
of response to treatment and survival time amongst women with advanced breast 
cancer (Coates et al. 1992;Kramer et al. 2000). Quite apart from potential survival 
benefits, enhancing quality of life by minimizing the physical and psychological 
impact of the disease and treatment side effects is an important endpoint in itself and 
should be the focus of health care for people with metastatic disease. Thus, it is 
critical for the treatment team to be aware of the impact of the disease and treatment 
on the quality of life of women with advanced breast cancer. 
 
Recently, it has been argued that quality of life assessments provide an outline of 
patient concerns or issues but fail to indicate which of the concerns the patients most 
feel they require assistance (Sanson-Fisher et al. 2000). Similarly, satisfaction 
measures provide little direction on how to ameliorate patient concerns. Ong and 
colleagues also question whether creating a 'satisfied' consumer is sufficient given that 
the purpose of medical care is to optimize the health and well-being of patients (Ong 
et al. 1995). Moreover, measures of satisfaction are notoriously susceptible to social 
desirability biases in responses (Ong et al. 1995). Hence, the concept of 'unmet needs' 
was developed. 
 
Unmet needs are defined as 'the requirement of some action or resource that is 
necessary, desirable or useful to attain optimal well-being' (Sanson-Fisher et al. 
2000). Previous research on the unmet needs of people with cancer has revealed that 
in general, people with cancer experience the highest levels of unmet needs in the 
areas of health information, especially in relation to the disease investigatory tests and 
treatments; psychological/social support concerns; and physical and daily living needs 
(Foot & Sanson-Fisher 1995; Luker et al. 1995; Bilodeau & Degner 1996; Meredith et 
al. 1996;Graydon et al. 1997; Newell et al. 1999; Sanson-Fisher et al. 2000; Soothill 
et al. 2003). In a local Australian study, by far the highest unmet need was in the 
domain of health information with over 60% of ambulatory patients with cancer 
expressing this need (McLachlan et al. 2001). However, small variations in findings 
are noted between studies, probably as a result of different measurement tools and 
different populations. 
 
Needs and quality of life issues tend to vary substantially according to the 
characteristics of the person. Research has shown that women express higher levels of 
unmet needs than men (Meredith et al. 1996;Sanson-fisher et al. 2000). Needs also 
change over the course of the disease (Luker et al. 1996; Degner et al. 1997;Frost et 
al. 2000). In comparison to others, people with advanced disease report higher levels 
of unmet needs in most domains but especially in the psychological and physical and 
daily living domains (Foot & Sanson-Fisher 1995; Sanson-fisher et al. 2000; Cossich 
et al. in press). 
 
The small amount of research focused on people with advanced cancer has shown that 
they experience unrelieved physical symptoms, especially pain, fatigue, dyspnoea and 
reduced appetite (Vachon et al. 1995; Stromgren et al. 2001; Wong et al. 2002); high 
levels of psychological distress, particularly for people who also reported pain 
(Vachon et al. 1995; Stromgren et al. 2001); and practical service needs, such as help 
with daily living, housework, financial assistance and transportation (Siegel et al. 
1991;Vachon et al. 1995; Wong et al. 2002). Self-care, mobility, physical activity, 
appetite and sleep were the quality of life issues ranked mostly highly important by 
women with advanced breast cancer (Sutherland et al. 1990). 
 
Owing to the difficulties inherent in recruiting people with metastatic disease into 
studies, this tends to be an under-researched group in terms of quality of life research 
(Kristjanson & Ashcroft 1994;Bottomley & Therasse 2002). The strength of the 
current study is that a sizeable group of women with metastatic disease from four 
different urban treatment centres were surveyed using reliable and valid instruments 
to assess quality of life and unmet needs. 
 
The aims of this study were: 
 
1  to identify support and information needs that are commonly experienced by urban 
women with advanced breast cancer; 
  
2  to identify patterns of support and information needs among these women; and 
  
3 to evaluate the variation of support and information needs by demographic and 
disease characteristics among these women. 
 
METHODS 
Setting 
 
This study was conducted at four large urban hospitals, three public and one private, 
in Melbourne, Australia. 
  
Sample 
 
A consecutive sample of 172 women with metastatic breast cancer who were 
attending an outpatient oncology clinic was screened for inclusion. Inclusion criteria 
for patients were as follows: a diagnosis of breast cancer that was newly diagnosed at 
an advanced stage, recurred or progressed in the preceding 12 months; aged 18 years 
or older; had sufficient English for the study requirements and had access to a 
telephone for follow-up. Of these 67 declined to participate for a variety of reasons, 
including being too tired, involvement in other studies and time commitments. This 
represents a response rate of 61%. All those who consented completed the baseline 
questionnaire (n = 105). 
  
Design and procedure 
 
This study was carried out with ethics committee approval from all study sites. The 
data reported in this study were collected at baseline for a pilot randomized controlled 
trial that assessed the effectiveness of an intervention designed to improve patients' 
quality of life and reduce their unmet needs. 
 
A breast care research nurse at each site reviewed the appointment schedule to 
identify potentially eligible women and confirmed their suitability with the treating 
doctor prior to the clinic. The breast care research nurse then placed a screening form 
on the patient's notes to alert the specialist involved in that woman's care. The doctor 
provided initial information about the study to the woman. If she was interested in 
participating, the breast care research nurse provided verbal and written information 
about the study and obtained written consent. The woman was then asked to complete 
the baseline questionnaire. The baseline questionnaire contained demographic 
questions, the European Organization of Research and Treatment of Cancer Quality of 
Life Q-C30 (EORTC QLQ-30) (version (2.0) (EORTC QLQ-30) and the Supportive 
Care Needs Questionnaire (SCNQ) and an interactions with health professionals 
checklist. The breast cancer nurse provided diagnostic and treatment details for each 
patient based on the patient's medical record. 
  
Measures 
 
EORTC QLQ-30 The quality of life questionnaire contains 30 items and was scored 
according to the algorithm in the EORTC QLC-30 scoring manual. Briefly, the raw 
score for each scale contained in the questionnaire is an average of the applicable 
items for that scale. All items for a particular scale are rated on the same range of 
values (i.e. 14). Raw scores are then linearly transformed to 0100 scales. High scores 
represent healthy functioning in the functional scales, high quality of life in the global 
health status quality of life scale and a high level of problems for symptom scales. 
Scales that were used in this study included the five functional scales, the global 
health status quality of life scale and the nine symptom scales from the core section of 
the EORTC QLC-30. It has demonstrated high reliability and concurrent criterion 
validity (Hjermstad et al. 1995;Kaasa et al. 1995). 
 
SCNQ The SCNQ contains 59 items designed to measure patients' perceived needs 
for help in five core domains: psychologic, health information, physical and daily 
living, patient care and support and sexuality, and single items assess communication, 
financial and transport needs. An additional 16 single items assess need for access to 
services and resources. Patients indicated for each item whether they are experiencing 
no need, low, moderate or high need for each item. Scores for summary scales are 
then linearly transformed 0100 average of the items contained in the scale. Higher 
scores indicate higher level of need. The transformed summary score for each domain 
and single items were used in the analyses as the primary outcome. As a secondary 
outcome, for each domain score, each woman was categorized as having a score in 
excess of 50 or 50 or below. Women with a score higher than 50 indicated that they 
have had moderate to high need across the items contained in the domain. It has high 
internal consistency and demonstrated construct and content validity (Bonevski et al. 
2000). 
  
Statistical analyses 
 
In all analyses, a P-value < 0.05 was considered statistically significant. Analyses 
were conducted using SPSS. Exact P-values were calculated using StatExact. The 
methods used to address each of the study aims are as follows. Response frequency 
for each SCNQ item was tabulated. Then, cluster and discriminant function methods 
were used to investigate the pattern of support and information needs. Only the five 
main multi-item SCNQ domains were used in the analysis. This was performed in 
stages. First, bivariate scatterplots of each domain were examined for evidence of 
clustering. Then, a hierarchical cluster analysis was used to produce a dendogram of 
agglomerative clusters of women with similarity in need. K means cluster analysis 
was then used to assign individual membership to clusters, with the number of 
clusters specified as those found in the examination of the dendogram. Two methods 
were used to validate this cluster structure. The dendogram was re-examined for 
consistency of membership assignment between the two methods of cluster analysis 
used. Discriminant function analysis was then used to validate the cluster structure. 
 
Two sets of analyses were conducted to investigate variation in unmet needs by 
demographic and disease characteristics. The first evaluated variation in demographic 
and disease characteristics within SCNQ summary scales. The second evaluated 
variation in demographic and disease characteristics between the clusters identified in 
the preceding analysis. Pearson chi-square was used to evaluate differences between 
dichotomous and non-ordered categorical variables. Fisher's exact test of significance 
was used where contingency tables contained one or more cells with an expected cell 
count less than five and the Pearson chi-square P-value was < 0.05. The 
KruskalWallis tests and MannWhitney tests of differences were used to evaluate 
differences in medians between categorical variables as appropriate. 
 
 
RESULTS 
Description of the sample 
 
Table 1 displays demographic details and disease characteristics for the sample. The 
median age of women was 57 years (range 3485), most were married, over half had 
adult children and a quarter had at least one child under 18 years. Most women (61%) 
reported having had previous contact with a breast care nurse; most of this contact had 
occurred around the time of initial treatment, that is, before surgery, just after surgery 
or during chemotherapy or radiotherapy. Women also reported having contact with a 
range of other health professionals. The most commonly seen health professionals 
were medical oncologists, chemotherapy nurses, general practitioners, radiation 
oncologists, radiotherapy nurses and surgeons. 
 
 
 
 
    No. % 
Age Median (range) years 
57 (34
85) 
  
Box Hill 19 18% 
Cabrini 29 28% 
Peter MacCallum 37 35% 
Clinic 
The Alfred 20 19% 
Never married 11 10% 
Married/de facto 67 64% 
Separated/divorced 15 14% 
Widowed 10 10% 
Marital status 
Unknown  2  2% 
School certificate 30 29% 
Higher school certificate 11 10% 
Certificate/diploma 11 10% 
University 
degree/diploma 
23 22% 
University higher degree  5  5% 
Other 22 21% 
Highest education 
Unknown  3  3% 
At least one child < 
18 years 
25 24% 
Adult children 56 53% 
No children 21 20% 
Children 
Unknown  3  3% 
Time since primary diagnosis Median (range) years 
 5 (< 1
27) 
  
Time since advanced disease 
diagnosed 
Median (range) years 
 1 (< 1
14) 
  
Time between primary diagnosis 
and diagnosis of advanced cancer 
Median (range) years 
 3 (< 1
24) 
  
Adenocarcinoma  6  6% Type of breast cancer 
Ductal carcinoma 43 41% 
    No. % 
Inflammatory breast 
carcinoma 
 2  2% 
Lobular 10 10% 
Ductal carcinoma, 
lobular 
 2  2% 
No details available 24 23% 
Unknown 18 17% 
0  3  3% 
1 32 30% 
2 35 33% 
3 25 24% 
4  7  7% 
5  2  2% 
Number of sites of metastases 
Unknown  1  1% 
Sites of metastatic disease 
No 23 22% 
Yes 81 77% 
Bone 
Unknown  1  1% 
No 94 90% 
Yes 10 10% 
Brain 
Unknown  1  1% 
No 74 70% 
Yes 29 28% 
Liver 
Unknown  1  1% 
No 72 69% 
Yes 32 30% 
Lung 
Unknown  1  1% 
No 59 56% 
Yes 45 43% 
Lymph nodes 
Unknown  1  1% 
No 89 85% 
Yes 15 14% 
Other 
Unknown  1  1% 
 
Table 1. Patient and disease characteristics 
 
 
The median time since primary diagnosis was 5 years (range < 127 years) and median 
time since diagnosis of advanced disease was 1 year (range < 114 years). The most 
common breast cancer was ductal carcinoma (41%). The vast majority of patients 
(87%) had between 1 and 3 metastatic sites: 77% of the women had bone metastases; 
43% had lymph node metastases; 30% lung metastases; 28% liver metastases; and 
10% brain metastases. 
 
Half the sample was currently receiving chemotherapy; 45% was receiving 
Aminohydroxypropylidene bisphosphonate (APD) treatment for boney metastatic 
disease (Pamidronate); 40% was receiving hormonal therapy; 15% radiotherapy; and 
5% surgery. Two women were not currently receiving treatment and the current 
treatment status was unknown for four women. 
  
The quality of life and support and information needs of women with advanced breast 
cancer 
 
Table 2 displays a summary of the EORTC Quality of Life questionnaire and SCNQ. 
For the EORTC QLQ-30 functioning scales, 26% of women scored 50 or below, 
representing worse quality of life, on the global health status scale, and between 27% 
and 30% of women scored 50 or below on the physical, role and social functioning 
scales. Only a small proportion of women had scores of 50 or below, on the emotional 
and cognitive functioning scales (14% and 8%, respectively). For the symptom scales, 
over half (63%) of women scored over 50 on the fatigue scale, which represents 
higher symptoms; 30% scored over 50 on the pain scale and 26% scored over 50 on 
the insomnia scale. 
 
 
 
 Mean SD Median  n < 50 % < 50 
Missing 
Data 
EORTC QLQ-30* 
Physical functioning 66 27 60 28 27% 0 
Role functioning 62 33 67 31 30% 0 
Emotional functioning 71 24 75 15 14% 1 
Cognitive functioning 77 24 83  8  8% 0 
Social functioning 63 31 67 28 27% 0 
Global health status 63 22 67 27 26% 0 
Symptom scales 
  Fatigue 42 26 33 66 63% 1 
  Nausea and vomiting 15 23  0 11 10% 0 
 Mean SD Median  n < 50 % < 50 
Missing 
Data 
  Pain 32 31 16 31 30% 0 
  Dyspnoea 22 24 33 12 11% 0 
  Insomnia 34 34 33 27 26% 1 
  Appetite loss 25 32  0 17 16% 0 
  Constipation 18 28  0 12 11% 0 
  Diarrhoea  9 19  0  6  6% 2 
  Financial difficulties 24 32  0 15 14% 0 
Supportive Care 
Needs Questionnaire 
            
Psychological needs 27 26 18 23 22% 0 
Health information 
needs 
26 28 16 23 22% 0 
Physical and daily 
living needs 
22 22 14 16 15% 0 
Patient care and 
support needs 
 9 15  2  3  3% 1 
Sexuality needs 26 27 22 15 15% 3 
*The EORTC summary scales range from 0 to 100 with a higher score indicating 
better quality of life on the function scales and a poorer outcome on the symptom 
scales. The SCNQ scales also range from 0 to 100 with a higher score indicating 
a higher level of need. 
All scales had a range from 0 to 100. 
Table 2. European Organization of Research and Treatment of Cancer Quality of Life 
(EORTC QLQ-30) and Supportive Care Needs Questionnaire (SCNQ) summary 
scales 
 
For the SCNQ, over one-fifth of women scored over 50 in psychological and health 
information domains, indicating higher level of need. The proportions were lower for 
the other domains. This finding was reflected in the results for the individual items 
(see Fig. 1). Of the top 20 unmet needs, 11 were from the psychological domain, 7 
from the health systems domain and 2 from the physical domain. The two items most 
commonly rated as moderate or high need were 'concerns about the worries of those 
close to you' (41%) and 'to be informed about things you can do to help yourself get 
well' (41%). The next most common items related to fears about the future and control 
over the situation, including being well informed. The items from the physical 
domain, which were 'pain' and 'not being able to do the things you used to', were 
ranked below 10 in the list. 
 
 
 
Figure 1. Top 20 unmet needs ranked by percentage patients with moderate or high 
need. 
 
 
In terms of services and resource needs, the five most commonly reported unmet 
needs were: 'easy car parking at the hospital or clinic' (33%); monetary allowance for 
travel, treatment or equipment expenses' (18%), 'drop in counselling services' (17%), 
24 h telephone support and cancer advisory service' (17%) and 'relaxation classes' 
(16%). See Figure 2. 
 
 
 
 
 
Figure 2. Service and resource needs ranked by percentage patients with moderate or 
high need. 
 
  
The interrelationship between the support and information needs 
 
 
 
Figure 3. Percentage of women with SCNQ domain score > 50 by cluster. 
 
 
Cluster analysis suggested that there were three main groups of women with different 
profiles of need across the five multi-item domains of the SCNQ. Figure 3 displays 
the percentage of women with SCNQ domain scores of greater than 50 by cluster. The 
largest group (n = 66) was substantially without moderate to high need in any of the 
SCNQ domains. In the second group (n = 26), many women had moderate or high 
need in the psychological and health information domains, while in the third group (n 
= 10) many women had moderate or high need in the psychological and physical and 
daily living domains. The mean of each domain varied by cluster (F d.f. = 2 ranged 
from 22 to 85, P < 0.001 for all domains). Discriminant function analysis suggested 
support for the existence of the clusters identified. The discriminant functions 
generated from this data set effectively separated the members of each cluster (Wilk's  
= 0.140, P < 0.001). However, when compared with the psychological, health 
information and physical and daily needs domains, the patient care and sexuality 
needs domains contributed substantially less to the discriminant functions generated. 
The psychological and health information needs are correlated at 0.70 and 0.58 with 
function 1 compared with 0.16 or less for the physical and daily living, patient care 
and support and sexuality needs domains. The second function is most highly 
correlated with the physical and daily living needs domain, all other correlations 
below 0.63 (absolute value). 
  
The variation of support and information needs by demographic and disease 
characteristics 
  
Demographic and medical characteristics by summary supportive care needs 
questionnaire scales 
The primary outcome for this analysis was median SCNQ score for each scale. A 
secondary analysis to confirm the results of the primary analyses was conducted with 
the SCNQ scale dichotomized into score  50 or > 50. Rate of SCNQ score by 
demographic characteristic was also investigated for the same variables. Of the six 
medical characteristics examined, only the median SCNQ score for the physical daily 
living domain varied by current radiotherapy. Women who were currently undergoing 
radiotherapy experienced comparatively greater physical and daily living needs (P = 
0.001). The median SCNQ score did not vary in any domain by number of metastatic 
sites, currently receiving chemotherapy, currently receiving APD treatment, years 
since breast cancer diagnosed, years since advanced breast cancer diagnosed or years 
between primary and advanced diagnosis (all P > 0.05). Women who had previously 
seen a breast care nurse were more likely to express unmet needs in the physical and 
daily living domain (P = 0.03). The median SCNQ scores for each of the domains did 
not vary by the remaining demographic and medical characteristics including age, 
martial status, education and having children (all P > 0.05). 
  
Demographic and disease characteristics by cluster 
The same set of demographic and medical characteristics as used above were included 
in these analyses. Demographic and disease characteristics did not vary across clusters 
(all P > 0.145). Similarly, there was no significant variation of treatment or metastatic 
site by cluster membership (all P > 0.054). 
 
 
DISCUSSION 
In terms of quality of life issues, a sizeable minority of women in this sample reported 
difficulties with their physical, role and social functioning. These difficulties were 
reflected in an overall assessment of health: over a quarter of the women reported 
poor global health status. Over half the women reported feeling fatigued. Pain and 
insomnia also represented difficulties for a sizeable minority of women. These 
findings broadly reflect previous research on quality of life issues for women with 
advanced breast cancer; although, it would appear that the level of physical symptoms 
reported is lower than in previous research (Sutherland et al. 1990;Vachon et al. 1995; 
Stromgren et al. 2001). This may be because advances in symptom management mean 
that symptoms are now better controlled than previously. Alternatively, it may be that 
this sample was captured earlier in the advanced stage of the disease in comparison to 
samples in previous research. Sub-analyses of median EORTC physical functioning 
scores and the physical and daily living needs score tend to support the better 
symptom management explanation. The median scores for both of these scales were 
comparatively lower for patients receiving APD treatment; however, these trends 
were not significant. It is a concern that pain and insomnia, which should be able to be 
controlled with appropriate medication, remain a problem for some women with 
advanced breast cancer. The reasons underlying this are likely to relate to failure of 
the health care system to identify and address these symptoms. 
 
In terms of unmet needs, the highest levels of unmet needs were from the 
psychological and health information domains. This is similar to findings for a 
heterogeneous sample of mixed cancer types and stages (Sanson-Fisher et al. 2000); 
however, inspection of rank ordering of individual items reveals that the needs of 
women with advanced cancer are different from the needs of the general category of 
people with cancer. In the heterogeneous sample (Sanson-Fisher et al. 2000), the top 
three concerns were 'fears about the cancer spreading'; 'fears about the cancer 
returning'; and 'concerns about the worries of those close to you'; whereas in this 
group of women with advanced breast cancer the rank order had shifted to 'concerns 
about the worries of those close to you'; 'to be informed about things you can do to 
help yourself get well'; and 'uncertainty about the future'. Hence, once the cancer was 
known to be incurable, fears about it advancing were replaced by self-care and control 
issues. These are both issues in which women may be assisted by information. In 
recent years, there have been increased efforts to provide patients with the 
information that they require (Jefford & Tattersall 2002); clearly there remains a need 
to develop new strategies for information dissemination. People prefer to receive 
information in different ways (Jefford & Tattersall 2002), in terms of the level of 
detail provided, the timing of presentation and the medium in which it is presented. 
Health systems need to cater for the range of preferences if information provision is to 
be optimized. 
 
Comparing service and resource needs in women with advanced cancer with the needs 
of a heterogeneous group (Sanson-Fisher et al. 2000), car parking and financial 
assistance top the list for both groups. However, compared with the heterogeneous 
sample, women with advanced breast cancer express greater need for counselling and 
support services. This is an appropriate response to their circumstances and may also 
relate to a higher inclination by women to seek emotional support. This finding does 
highlight the need to ensure that these women have adequate opportunity to access the 
supportive care services available in hospitals, such as breast care nurses. 
 
Interestingly, there were almost no differences detected in unmet needs in terms of 
demographic and disease characteristics of the women. This reinforces that no 
assumptions should be made about the needs of any woman with advanced breast 
cancer on the basis of her demographic and disease characteristics. This is not to say 
that women do not differ in their level of unmet needs. These results also suggested 
that there exists three broad types of women with advanced breast cancer: women 
with a low level of unmet need in all domains; women with primarily psychological 
and health information unmet needs; and women with psychological and physical and 
daily living unmet needs. This was considered an exploratory analysis with the aim of 
simplifying a complex set of data into a structure that could then be used for future 
supportive care planning. 
 
Addressing these issues is critical to providing optimal care of women with advanced 
breast cancer. Hence, the first aspect of care should be regular monitoring of the 
person's needs and quality of life. This information can then be used to plan or modify 
treatment regimens and provide the woman with the information or services that she 
requires. Routine screening questionnaires are increasingly being introduced into 
clinical practice (Zabora et al. 2003). Recent research has found that touch screen 
computers are an acceptable way of gathering and disseminating this information to 
the health care team (Allenby et al. 2002). In the absence of formal mechanisms for 
obtaining this information, health care teams can just ask the woman about her quality 
of life and her needs. Use of open-ended questions, active listening, responding with 
empathy and clarifying perceptions of woman's concerns are all strategies that have 
been shown to increase the identification of patients' concerns (Ryan et al. in press). 
 
This study provides important information on an under-researched group; however, 
there are a number of limitations that should be noted. The sample was drawn from 
four large urban Australian hospitals, three public and one private. The needs of rural 
women and women who do not speak English are not represented in these findings 
and may well be different from those of urban, English-speaking women. Also, the 
consent rate would be generally considered low for survey research. However, 
considering this group had metastatic disease and they were being asked to consent to 
a randomized controlled trial involving completing three surveys over a 3-month 
period, the consent rate may be considered reasonable in this context. Nevertheless, 
there may be some bias in the sample, especially as one of the reasons given for non-
consent was tiredness, which suggests that the views of women with poorer health 
status may have been missed. 
 
Addressing the quality of life issues and unmet needs of urban women with advanced 
breast cancer is not only likely to benefit the women and their families but may also 
reduce their use of the health care system. Patients with unmet psychological needs 
have higher utilization of medical services, higher medical costs and longer hospital 
stays than non-depressed patients (Fulop et al. 1987;Levenson et al. 1990;Simon et al. 
1995) and therefore place an added burden on the health system. In the face of 
incurable disease, quality of life outcomes and meeting the patient's needs are the 
most important outcomes of management. Interventions that have been demonstrated 
to address these needs are urgently required. 
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